European Consensus Conference on Diagnosis and Treatment of Germ Cell Cancer: A Report of the Second Meeting of the European Germ Cell Cancer Consensus group (EGCCCG): Part IS. Krege, Ó. Leiva Galvis, Maike de Wit et al.|European Urology|2008Cited by 617
European Consensus Conference on Diagnosis and Treatment of Germ Cell Cancer: A Report of the Second Meeting of the European Germ Cell Cancer Consensus Group (EGCCCG): Part IIS. Krege, Ó. Leiva Galvis, Rainer Souchon et al.|European Urology|2008Cited by 252
Progression free survival of first line vascular endothelial growth factor-targeted therapy is an important prognostic parameter in patients with metastatic renal cell carcinomaChristoph Seidel, Viktor Grünwald, Jonas Busch et al.|European Journal of Cancer|2012Cited by 54
Efficacy of Sunitinib Re-Exposure after Failure of an mTOR Inhibitor in Patients with Metastatic RCCViktor Grünwald, Manfred Johannsen, Steffen Weikert et al.|Onkologie|2011Cited by 42
Corrigendum to: “European Consensus Conference on Diagnosis and Treatment of Germ Cell Cancer: A Report of the Second Meeting of the European Germ Cell Cancer Consensus group (EGCCCG): Part I” [Eur Urol 2008;53:478–96] and to: “European Consensus Conference on Diagnosis and Treatment of Germ Cell Cancer: A Report of the Second Meeting of the European Germ Cell Cancer Consensus group (EGCCCG): Part II” [Eur Urol 2008;53:497–513]S. Krege, Ó. Leiva Galvis, Rainer Souchon et al.|European Urology|2008Cited by 7